Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Duchenne Muscular Dystrophy (DMD) Therapeutics
1.2 Key Market Segments
1.2.1 Duchenne Muscular Dystrophy (DMD) Therapeutics Segment by Type
1.2.2 Duchenne Muscular Dystrophy (DMD) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Competitive Landscape
3.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Sites, Area Served, Product Type
3.6 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Competitive Situation and Trends
3.6.1 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Duchenne Muscular Dystrophy (DMD) Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Chain Analysis
4.1 Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Duchenne Muscular Dystrophy (DMD) Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Price by Type (2019-2024)
7 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Sales by Application (2019-2024)
7.3 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Growth Rate by Application (2019-2024)
8 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Segmentation by Region
8.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Sales by Region
8.1.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Sales by Region
8.1.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Duchenne Muscular Dystrophy (DMD) Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Duchenne Muscular Dystrophy (DMD) Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Duchenne Muscular Dystrophy (DMD) Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Sarepta Therapeutics
9.1.1 Sarepta Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Basic Information
9.1.2 Sarepta Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Product Overview
9.1.3 Sarepta Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Product Market Performance
9.1.4 Sarepta Therapeutics Business Overview
9.1.5 Sarepta Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics SWOT Analysis
9.1.6 Sarepta Therapeutics Recent Developments
9.2 PTC Therapeutics
9.2.1 PTC Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Basic Information
9.2.2 PTC Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Product Overview
9.2.3 PTC Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Product Market Performance
9.2.4 PTC Therapeutics Business Overview
9.2.5 PTC Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics SWOT Analysis
9.2.6 PTC Therapeutics Recent Developments
9.3 Pfizer
9.3.1 Pfizer Duchenne Muscular Dystrophy (DMD) Therapeutics Basic Information
9.3.2 Pfizer Duchenne Muscular Dystrophy (DMD) Therapeutics Product Overview
9.3.3 Pfizer Duchenne Muscular Dystrophy (DMD) Therapeutics Product Market Performance
9.3.4 Pfizer Duchenne Muscular Dystrophy (DMD) Therapeutics SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Duchenne Muscular Dystrophy (DMD) Therapeutics Basic Information
9.4.2 Bristol-Myers Squibb Duchenne Muscular Dystrophy (DMD) Therapeutics Product Overview
9.4.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy (DMD) Therapeutics Product Market Performance
9.4.4 Bristol-Myers Squibb Business Overview
9.4.5 Bristol-Myers Squibb Recent Developments
9.5 Italfarmaco
9.5.1 Italfarmaco Duchenne Muscular Dystrophy (DMD) Therapeutics Basic Information
9.5.2 Italfarmaco Duchenne Muscular Dystrophy (DMD) Therapeutics Product Overview
9.5.3 Italfarmaco Duchenne Muscular Dystrophy (DMD) Therapeutics Product Market Performance
9.5.4 Italfarmaco Business Overview
9.5.5 Italfarmaco Recent Developments
9.6 Santhera Pharmaceuticals
9.6.1 Santhera Pharmaceuticals Duchenne Muscular Dystrophy (DMD) Therapeutics Basic Information
9.6.2 Santhera Pharmaceuticals Duchenne Muscular Dystrophy (DMD) Therapeutics Product Overview
9.6.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy (DMD) Therapeutics Product Market Performance
9.6.4 Santhera Pharmaceuticals Business Overview
9.6.5 Santhera Pharmaceuticals Recent Developments
10 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast by Region
10.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Forecast
10.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Forecast by Region
10.2.4 South America Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Duchenne Muscular Dystrophy (DMD) Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Duchenne Muscular Dystrophy (DMD) Therapeutics by Type (2025-2030)
11.1.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Duchenne Muscular Dystrophy (DMD) Therapeutics by Type (2025-2030)
11.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings